ArticleBMC oral health2025
Association between salivary soluble RANKL, OPG concentration and mandibular resorption to clinically predict severe residual ridge resorption risk: a cross-sectional study.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe insidious progression of residual ridge resorption (RRR) following tooth extraction remains a formidable clinical challenge in contemporary dentistry. Understanding its underlying cellular and molecular mechanisms is key to developing both patient-specific risk assessments for preventive care and novel therapies to arrest bone loss. Salivary bone turnover biomarkers show promise as a non-invasive method for evaluating the rate of bone loss. This research aimed to identify the association of salivary receptor activator of nuclear factor-KB ligand (RANKL), and osteoprotegerin (OPG) levels with resorbed mandibular edentulous ridges, proposing a clinical tool for identifying high resorption risk.
methodsThe mandibular ridge height was determined radiographically on 140 systematically healthy edentulous participants. Based on the Cawood and Howell system and the American College of Prosthodontists classification, the subjects were categorized as severe or normal resorption. Complete denture clinical quality was assessed using the Chulalongkorn University-modified Kapur criteria. Whole unstimulated salivary was collected, and salivary RANKL and OPG protein levels were quantified by enzyme-linked immunosorbent assay technique. Logistic regression analysis was used to develop a risk assessment model for severe resorption. Nomograms were generated from the final model to estimate the risk of RRR.
resultsExcessive RRR were found in a notably higher percentage of women (36.43%) versus men (13.57%). A strong association between severe RRR and RANKL, OPG concentration, denture quality, edentulous duration was found. Elevated RANKL levels were significantly associated with increased alveolar bone loss, with each 10 pg/ml increase corresponding to a 4-fold and 3.5-fold increase in RRR odds for women and men, respectively. Conversely, higher OPG levels showed a protective effect; for every 10 pg/ml increase, the RRR odds decreased by 60% for women and 73% for men. To estimate accelerated bone resorption risk, a nomogram with high predictive accuracy (AUC = 0.94) was developed using edentulous duration and RANKL level.
conclusionsSalivary RANKL and OPG levels are strongly associated with the severity of RRR, with gender differences observed in resorbed mandibular. Elevated RANKL increases RRR risk, while higher OPG offers a protective effect. This study’s novel nomogram offers a practical chairside tool to assess this risk, enabling tailored patient counseling and proactive treatment plans to preserve mandibular bone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.